Interros

Interros is a major Russian private investment group founded in 1990 by Vladimir Potanin, with a diversified portfolio that includes a significant presence in the life sciences and pharmaceutical sectors. The company's primary healthcare asset is Petrovax Pharm, one of Russia's leading biopharmaceutical developers and manufacturers. Through Petrovax, Interros is involved in the production of innovative vaccines, such as the Grippol series, and original immunomodulators like Polyoxidonium. The group also engages in strategic partnerships with global pharmaceutical giants like Pfizer and Boehringer Ingelheim to localize the production of essential medicines in the Russian market. Interros's involvement in the sector spans the entire value chain, from R&D and clinical trials to large-scale GMP manufacturing and commercial distribution. This strategic focus positions Interros as a key player in the Eurasian pharmaceutical market, driving advancements in immunology and infectious disease prevention.